as on October 28, 2025 at 1:29 am IST
Day's Low
Day's High
0.51%
Downside
1.41%
Upside
52 Week's Low
52 Week's High
7.57%
Downside
85.55%
Upside
Check Haemonetics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.5B
EPS (TTM)
4.5443
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.05%
PE Ratio (TTM)
15.68
Industry PE ratio
8.355964912280701
PEG Ratio
1.2149
EBITDA
369.6M
Revenue (TTM)
1.3B
Profit Margin
12.14%
Return On Equity TTM
18.27%
Track how Haemonetics Corp P/E has moved over time to understand its valuation trends.
Haemonetics Corp in the last 5 years
Lowest (13.34x)
September 30, 2025
Industry (8.36x)
October 28, 2025
Today (15.68x)
October 28, 2025
Highest (52.66x)
March 31, 2021
Today’s Price to Earnings Ratio: 15.68x
Compare market cap, revenue, PE, and other key metrics of Haemonetics Corp with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.5B | -50.5% | 15.68 | 12.14% | |
| BUY | $149.8B | 200.65% | 54.07 | 14.43% | |
| BUY | $146.0B | 87.23% | 50.5 | 12.25% | |
| BUY | $220.8B | 19.51% | 15.92 | 31.88% | |
| BUY | $120.1B | -8.25% | 25.88 | 13.63% |
The Haemonetics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Haemonetics Corp investment value today
Current value as on today
₹72,670
Returns
Returns from Haemonetics Corp Stock
Dollar Returns*
₹5,074 (+5.07%)
Based on 11 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 11 analysts, 72.73% of analysts recommend a 'BUY' rating for Haemonetics Corp. Average target price of $76.27
Get share price movements and forecasts by analysts on Haemonetics Corp.
What analysts predicted
32.88%UPSIDE
Target Price
$76.27
Current Price
$51.19
Analyzed by
11 Analysts
Target
$76.27
Haemonetics Corp target price $76.27, a slight upside of 32.88% compared to current price of $51.19. According to 11 analysts rating.
Search interest for Haemonetics Corp Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Boston Scientific Corp. has given 20.8% return, outperforming this stock by 53.2%
Against Peers
![]()
In the last 3 years, Boston Scientific Corp. has given 137.3% return, outperforming this stock by 176.0%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 348.54M → 321.39M (in $), with an average decrease of 4.0% per quarter
Price Dip
![]()
In the last 3 months, HAE stock has moved down by -31.4%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 57.98M → 34.03M (in $), with an average decrease of 41.3% per quarter
| Organisation | Haemonetics Corp |
| Headquarters | 125 Summer Street, Boston, MA, United States, 02110 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Simon |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Farris Maryanne Maunsell | VP, Chief Accounting Officer & Principal Accounting Officer |
Ms. Olga Guyette | Senior Director of Investor Relations |
Dr. Jan Hartmann M.D. | Senior VP & Chief Medical Officer |
Mr. Christopher A. Simon | CEO, President & Director |
Mr. James C. D'Arecca CPA | CFO, Executive VP & Financial Officer |
Mr. Frank W. Chan Ph.D. | Executive VP & COO |
Mr. Rajeev Varma | Senior Vice President of Strategy & Corporate Development |
Ms. Laurie A. Miller | Senior VP & Chief Human Resources Officer |
Ms. Michelle L. Basil Esq., J.D. | Executive VP, General Counsel & Secretary |
Mr. Roy Galvin | Executive VP & Chief Commercial Officer |
Haemonetics Corp share price today is $51.19 as on at the close of the market. Haemonetics Corp share today touched a day high of $51.91 and a low of $50.93.
Haemonetics Corp share touched a 52 week high of $94.99 on and a 52 week low of $47.32 on . Haemonetics Corp stock price today i.e. is closed at $51.19,which is 46.11% down from its 52 week high and 8.19% up from its 52 week low.
Haemonetics Corp market capitalisation is $0.00T as on .
Indian investors can start investing in Haemonetics Corp (HAE) shares with as little as ₹88.189 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.89 in Haemonetics Corp stock (as per the Rupee-Dollar exchange rate as on ).
Based on Haemonetics Corp share’s latest price of $51.19 as on October 28, 2025 at 1:29 am IST, you will get 0.1954 shares of Haemonetics Corp. Learn more about
fractional shares .
Haemonetics Corp stock has given -50.5% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?